Opportunity Information: Apply for RFA AG 20 001
The Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional) funding opportunity (RFA-AG-20-001) is a National Institutes of Health (NIH) discretionary grant program that supports the creation or continued operation of Research and Development Centers using the P30 center mechanism. The goal is to strengthen population-based social science research on aging by building shared infrastructure, expertise, and coordinated activities that help multiple investigators produce rigorous, policy-relevant research on how and why aging outcomes vary across people, places, and time. While the announcement is labeled "clinical trial optional," the emphasis of the program is on demography and economics of aging and related interdisciplinary work grounded in population-level social science approaches.
The FOA is especially interested in center applications that focus on several high-priority topic areas. One major emphasis is socioeconomic status (SES) disparities at older ages, including how outcomes differ by geography, which can include neighborhood, rural versus urban location, state policy context, or regional economic conditions. Another priority is research that helps explain why the United States performs poorly on health and mortality metrics when compared with other countries, encouraging work that can unpack the roles of social conditions, health systems, behaviors, and policy environments. The FOA also highlights trends and dynamics in old-age disability, pointing toward research that tracks disability incidence, recovery, progression, and the factors that shape those patterns over time.
In addition, the FOA encourages work on cohort trends in obesity and its sequelae, meaning research on how obesity patterns differ across birth cohorts and how those patterns translate into later-life health consequences such as diabetes, cardiovascular disease, disability, and mortality. Family demography is another core area of interest, particularly the demography of care and caregiving tied to chronic disease, disability, and Alzheimers Disease and Alzheimers-Related Dementias (AD/ADRD). This includes questions about who provides care, how caregiving responsibilities are distributed across families and communities, how caregiving intersects with labor force participation and economic security, and how these patterns are changing with family structure and population aging. Finally, the FOA places explicit emphasis on long-term supports and services for disabled older adults, which can include formal and informal care systems, service availability and financing, and the implications for individuals, families, and public programs.
Eligible applicants are broad and include many types of U.S.-based organizations and governments. Public and state-controlled institutions of higher education and private institutions of higher education are eligible, along with nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses. Government eligibility spans state, county, and city/township governments, special district governments, independent school districts, public housing authorities/Indian housing authorities, and federally recognized Native American tribal governments, as well as Native American tribal organizations that are not federally recognized tribal governments. The FOA also explicitly calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
The eligibility rules around international involvement are specific. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply as components. However, foreign components are allowed as defined in the NIH Grants Policy Statement, meaning a U.S. applicant center may include certain foreign elements when they are justified and comply with NIH policy, even though a foreign institution cannot be the primary applicant.
From the available source details, the program is listed under CFDA 93.866 and had an original closing date of 2019-06-03, with an award ceiling shown as $545,000. The FOA indicates an expected number of awards, though the specific number is not provided in the text you supplied. Overall, this opportunity is designed for institutions that want to build a sustained, collaborative center focused on aging-related population science, with a strong emphasis on disparities, international health comparisons, disability and obesity trends, caregiving and AD/ADRD-related family dynamics, and long-term supports and services for older adults with disabilities.Apply for RFA AG 20 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2018-10-30.
- Applicants must submit their applications by 2019-06-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $545,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional) - RFA-AG-20-001
What is this funding opportunity?
This is a National Institutes of Health (NIH) discretionary grant funding opportunity titled "Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional)" (RFA-AG-20-001). It uses the P30 center mechanism to support the creation or continued operation of Research and Development Centers.
What is the main purpose of the P30 center program described here?
The purpose is to strengthen population-based social science research on aging by building shared infrastructure, expertise, and coordinated activities that help multiple investigators produce rigorous, policy-relevant research on how and why aging outcomes vary across people, places, and time.
Is this opportunity focused on clinical trials?
The announcement is labeled "clinical trial optional," but the emphasis is on demography and economics of aging and related interdisciplinary work grounded in population-level social science approaches.
What kinds of research themes does the FOA prioritize?
The FOA highlights several high-priority topic areas, including socioeconomic disparities at older ages, U.S. health and mortality comparisons with other countries, disability trends and dynamics in old age, cohort trends in obesity and related health consequences, family demography related to care and caregiving (including AD/ADRD), and long-term supports and services for disabled older adults.
What does the FOA mean by socioeconomic status (SES) disparities at older ages?
It refers to differences in outcomes among older adults that are associated with socioeconomic conditions, including how outcomes differ by geography. Examples of geographic context mentioned include neighborhood characteristics, rural versus urban location, state policy context, and regional economic conditions.
How does geography fit into the research priorities?
Geography is explicitly included under the SES disparities priority area. The FOA is interested in how aging outcomes differ across places such as neighborhoods, rural versus urban areas, states (including policy context), and regions (including economic conditions).
What does the FOA say about comparing the United States to other countries?
The FOA encourages research that helps explain why the United States performs poorly on health and mortality metrics compared with other countries. It specifically points to investigating the roles of social conditions, health systems, behaviors, and policy environments.
What types of disability research are emphasized?
The FOA highlights trends and dynamics in old-age disability, including research that tracks disability incidence, recovery, progression, and the factors shaping those patterns over time.
What does "cohort trends in obesity and its sequelae" mean in this context?
It refers to research on how obesity patterns differ across birth cohorts and how those differences translate into later-life consequences such as diabetes, cardiovascular disease, disability, and mortality.
What is meant by "family demography" as a topic area?
Family demography is described as a core area of interest, particularly the demography of care and caregiving tied to chronic disease, disability, and Alzheimer's Disease and Alzheimer's-Related Dementias (AD/ADRD).
What caregiving questions does the FOA highlight?
The FOA points to questions such as who provides care, how caregiving responsibilities are distributed across families and communities, how caregiving intersects with labor force participation and economic security, and how these patterns are changing with family structure and population aging.
Does the FOA specifically mention AD/ADRD?
Yes. The FOA explicitly references Alzheimer's Disease and Alzheimer's-Related Dementias (AD/ADRD) in the context of caregiving and family demography.
What are "long-term supports and services" in the context of this FOA?
The FOA emphasizes long-term supports and services for disabled older adults. This can include formal and informal care systems, service availability and financing, and implications for individuals, families, and public programs.
What mechanism does NIH use for this opportunity?
This opportunity uses the P30 center mechanism to support Research and Development Centers.
Who is eligible to apply?
Eligible applicants are broad and include U.S.-based organizations and governments. Examples include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, and various eligible government entities.
Which types of government entities are eligible?
Government eligibility includes state governments, county governments, city/township governments, special district governments, independent school districts, public housing authorities/Indian housing authorities, federally recognized Native American tribal governments, and Native American tribal organizations that are not federally recognized tribal governments. The FOA also includes eligible federal agencies and U.S. territories or possessions.
Are minority-serving institutions specifically included as eligible applicants?
Yes. The FOA explicitly calls out eligibility for several categories, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations among the eligible applicant categories.
Are regional organizations eligible to apply?
Yes. The FOA explicitly includes regional organizations as eligible applicants.
Can a non-U.S. (foreign) organization apply as the main applicant?
No. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization.
Can a U.S. organization include a non-U.S. component as part of its application?
Non-domestic components of U.S. organizations are not eligible to apply as components. However, foreign components may be allowed as defined in the NIH Grants Policy Statement, meaning a U.S. applicant center may include certain foreign elements when justified and compliant with NIH policy, even though a foreign institution cannot be the primary applicant.
What does "foreign components are allowed" mean here?
It means that while foreign institutions cannot be the primary applicant (and non-domestic components of U.S. organizations are not eligible as components), the application may include certain foreign elements if they meet the NIH definition of a foreign component and are justified and compliant with NIH policy.
What is the CFDA number associated with this program?
The program is listed under CFDA 93.866 based on the provided details.
What is the maximum award amount (award ceiling) shown in the provided details?
The award ceiling shown in the provided details is $545,000.
What was the original closing date listed in the provided details?
The original closing date shown in the provided details is 2019-06-03.
How many awards are expected?
The FOA indicates an expected number of awards, but the specific number is not provided in the information supplied here.
What types of outcomes is this program trying to influence?
Based on the description provided, the program aims to strengthen rigorous, policy-relevant research capacity and coordination around aging outcomes, including disparities across socioeconomic groups and geographies, international differences in health and mortality, patterns of disability and obesity across time and cohorts, caregiving dynamics (including AD/ADRD), and long-term supports and services for disabled older adults.
What kinds of activities does a center supported by this FOA typically enable?
The FOA emphasizes building shared infrastructure, expertise, and coordinated activities designed to support multiple investigators producing population-based social science research on aging. Specific required components are not described in the information provided here.
Browse more opportunities from the same category: Health
Next opportunity: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Previous opportunity: Buenos Aires Provincial Youth Leaders Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 20 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 20 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional) Apply for RFA AG 20 002 Funding Number: RFA AG 20 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed) Apply for PA 19 043 Funding Number: PA 19 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) Apply for PA 19 046 Funding Number: PA 19 046 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional) Apply for PA 19 047 Funding Number: PA 19 047 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) Apply for PAR 19 048 Funding Number: PAR 19 048 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed) Apply for PA 19 049 Funding Number: PA 19 049 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Sustainable Access for Expanded Voluntary Medical Male circumcision (VMMC) Services (SAFE) Apply for SOURCES SOUGHT NOTICE 2018 Funding Number: SOURCES SOUGHT NOTICE 2018 Agency: Tanzania USAID-Dar es Salaam Category: Health Funding Amount: Case Dependent |
| Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) Apply for RFA AG 20 004 Funding Number: RFA AG 20 004 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed) Apply for PAR 19 061 Funding Number: PAR 19 061 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) Apply for PA 19 067 Funding Number: PA 19 067 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 053 Funding Number: RFA AI 18 053 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) Apply for PA 19 066 Funding Number: PA 19 066 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) Apply for PA 19 068 Funding Number: PA 19 068 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed) Apply for RFA DE 19 008 Funding Number: RFA DE 19 008 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed) Apply for RFA DE 19 009 Funding Number: RFA DE 19 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional) Apply for RFA AA 19 005 Funding Number: RFA AA 19 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 19 070 Funding Number: PAR 19 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) Apply for PAR 19 071 Funding Number: PAR 19 071 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 18 057 Funding Number: RFA AI 18 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R21 Clinical Trial Optional) Apply for RFA MH 19 411 Funding Number: RFA MH 19 411 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.